Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY)

Diabetes Care

Volumn 33, Issue 2, 2010, Pages 290-292

  Cuesta Mũnoz, Antonio L ^a   Tuomi, Tiinamaija ^b   Cobo Vuilleumier, Nadia ^a   Koskela, Hanna ^b   Odili, Stella ^c   Stride, Amanda ^d   Buettger, Carol ^c   Otonkoski, Timo ^e   Froguel, Philippe ^f   Grimsby, Joseph ^g   Garcia Gimeno, Maria ^h   Matschinsky, Franz M ^c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d PENINSULA MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF HELSINKI   (Finland)

^f CNRS   (France)

^g Hoffman La Roche Department of Metabolic Diseases   (United States)

^h INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CODON; COMPARATIVE STUDY; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY; FEMALE; GENE; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HETEROZYGOTE; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INFANT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MISSENSE MUTATION; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD;

ADULT; BLOOD GLUCOSE; CODON; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; GLUCOKINASE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MUTATION; YOUNG ADULT;

EID: 75149187014     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0681     Document Type: Article

References (12)

1. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P. Familial hyperglycemia due to mutations in glucokinase. N Engl J Med 1993;328:697-702
2. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971-980
3. Stride A, Vaxillaire M, Tuomi T, Barbetti F, Njølstad PR, Hansen T, Costa A, Conget I, Pedersen O, Søvik O, Lorini R, Groop L, Froguel P, Hattersley AT. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 2002;45:427-435
4. Ellard S, Bellanné-Chantelot C, Hattersley AT, the European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008;51: 546-553
5. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract Endo Metab 2008;4: 200-213
6. Fajans SS, Bell GI. Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees. Diabetologia 2006;49:1106-1108
7. Lehto M, Tuomi T, Mahtani MM, Widén E, Forsblom C, Sarelin L, Gullström M, Isomaa B, Lehtovirta M, Hyrkkö A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen MR, Groop L. Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect. J Clin Invest 1997; 99:582-591
8. Davis EA, Cuesta-Muñoz A, Raoul M, Buettger C, Sweet I, Moates M, Magnuson MA, Matschinsky FM. Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia 1999;42:1175-1186
9. Matschinsky FM. Assessing the potential of glucokinase activators in diabetes therapy. Nat Rev Drug Discov 2009;8:399-416
10. Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF. Allosteric activators of glucokinase: potential role in diabetes therapy. Science 2003;301:370-373
11. Martin D, Bellanné-Chantelot C, Deschamps I, Froguel P, Robert J-J, Velho G. Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2). Diabetes Care 2008; 31:1321-1323
12. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knockouts using Cre recombinase. J Biol Chem 1999;274:305-315